Evidence map›Paper›PMID 42226486›Full record

ArticleLangmuir : the ACS journal of surfaces and colloids2026

Affinity of Oxybenzone and Avobenzone toward Lipids in Model Membrane Systems: On the Role of Membranes in the Harmful Effect of UV Filters on Living Organisms.

Karolina Olechowska, Beata Wyżga, Katarzyna Hąc-Wydro

Abstract read
In one paragraph

Article in Langmuir : the ACS journal of surfaces and colloids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Karolina OlechowskaJagiellonian University, Faculty of Chemistry, Gronostajowa 2, Kraków 30-387, Poland.ORCID 0000-0002-2490-5387
Beata WyżgaJagiellonian University, Faculty of Chemistry, Gronostajowa 2, Kraków 30-387, Poland.
Katarzyna Hąc-WydroJagiellonian University, Faculty of Chemistry, Gronostajowa 2, Kraków 30-387, Poland.ORCID 0000-0003-3470-0403

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Avobenzone (Avo) and oxybenzone (Oxy) are organic UV filters that are consistently released into the environment and extensively studied in terms of their toxicity and bioaccumulation potential. This study aimed to verify the affinity of these compounds and their mixture to model membranes (lipid monolayers) and to discuss the potential role of lipids in the harmful effects of Avo and Oxy on living organisms. The experiments were performed for structurally different lipids building the membranes of, e.g., mammals, fish, or crustaceans: phosphatidylcholine, phosphatidylethanolamine, sphingomyelin, and cholesterol, and for a monolayer imitating adipocyte membranes. On the basis of the surface pressure/area isotherms, the penetration studies, and Brewster angle microscopy, the following conclusions were drawn. Avobenzone and oxybenzone affect the monolayer properties by increasing their fluidity, decreasing stability, and inducing morphological changes. Although Avo reveals a significantly stronger effect than Oxy, both filters show selectivity in their interactions with the lipids. The studies on the mixed monolayers indicate that not only the lipid type but also their content in the membrane correlates with the impact of UV filters. Finally, the direct influence of Avo and Oxy on the biomembrane may not be the ground for their toxicity mechanism; however, their affinity to particular lipids may correlate with their bioaccumulation potential.

Indexed as

BenzophenonesPropiophenonesSunscreening AgentsAnimalsUltraviolet RaysavobenzoneBenzophenonesoxybenzonePropiophenonesSunscreening Agents

Identifiers

PMID42226486
PMCPMC13362194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.